January 18, 2017 / 7:05 AM / 7 months ago

BRIEF-Panacea Biotec gets ANDA approval to market generic version of rizatriptan benzoate tablet

Jan 18 (Reuters) - Panacea Biotec Ltd

* Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT)

* Panacea Biotec Ltd says plans to launch product within Q1 2017 via distribution partner in US

* Panacea Biotec Ltd says drug used for treatement of migraine in adults and pediatric patients Source text - (bit.ly/2jISFEc) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below